RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
RenovaCare 2021 Outlook RenovaCare Discusses 2020 Highlights and Provides 2021 Outlook RenovaCare Chairman & CEO, Alan L. Rubino Alan L....
Day: December 22, 2020
Vaxil Retains Investor Engagement and Marketing Firm
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...
Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During “J.P. Morgan Week 2021”
HOUSTON, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients...
Resverlogix Announces Apabetalone Treatment Prior to SARS-CoV-2 (COVID-19) Exposure Significantly Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
Latest publication confirms BET inhibitors reduce the levels of critical receptors used by SARS-CoV-2 (COVID-19) to gain entry into cells,...
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery...
Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market
Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the US Builds upon the promising safety and...
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration...
FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
SAN FRANCISCO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the...
THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant Than Ever
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and...
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern TimeNEW YORK, Dec. 22, 2020 (GLOBE...
BioCryst Provides Update on Galidesivir Program
RESEARCH TRIANGLE PARK, N.C., Dec. 22, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that data from part...
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight and...
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
Single Local Treatment of OncoPLEX Showed Improved Overall Survival and Significantly Less Tumor Recurrence, and Reduced Systemic Toxicity Compared to...
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
University of Geneva Technology Covers Broad Applications for Cardiometabolic SyndromesCHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding...
Allarity Therapeutics Draws Down the Third Tranche Under Its Convertible Note Agreement with Negma Group LTD and Park Partners GP
Press Release Hørsholm, Denmark (22 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it...
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK,...
HEXO Corp Announces Lapse of Base Shelf Prospectus
OTTAWA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that its amended...
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)
Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase...